Avelos Therapeutics Email Formats
Biotechnology Research • 
3F, 21 Magokjungang 8-ro 7-gil, Korea, Republic of • 1-10 Employees
Key Contact at Avelos Therapeutics
Kiseon Baek
Assistant Director
Company overview
| Headquarters | 3F, 21 Magokjungang 8-ro 7-gil, Gangseo-gu, Seoul, 07794, KR |
| Phone number | +82269494369 |
| Website | |
| NAICS | 541714 |
| Founded | 2021 |
| Employees | 1-10 |
| Socials |
About Avelos Therapeutics
Avelos Therapeutics develops next-generation targeted oncology medicines with high unmet need, to a wider range of possibilities with present and future applications, especially in the areas of cell cycle regulation, undruggable cancer targets, and DNA damage response with a primary focus on synthetic lethality.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Manager
C-Suite
Director
Employees by Department
Avelos Therapeutics has 4 employees across 3 departments.
Departments
Number of employees
Funding Data
Explore Avelos Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
United States
United Kingdom
Bangladesh
Canada
Frequently asked questions
Avelos Therapeutics is located in 3F, 21 Magokjungang 8-ro 7-gil, KR.
You can reach Avelos Therapeutics at +82269494369.
Avelos Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.
Avelos Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
Avelos Therapeutics has raised a total of $20,400,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.
4.8
40,000 users
